Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Xperi Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
Revenue
376
486
502
521
494
448
Cost of revenue
77.8
126
123
119
114
127
Gross profit
298
361
379
403
380
321
Research and development
163
195
216
223
191
135
Selling, general and administrative
173
200
217
233
218
182
Operating income
-153
-162
-749
-130
-87.1
-43.7
Interest expense
1.51
3
3.01
2.98
Other non-operating income
1.54
1.59
1.82
-0.01
Pre-tax income
-151
-160
-748
-130
11.6
-40.6
Income tax
-9.74
18.8
13.6
10
12.4
15.7
Net income to minority interests
-2.97
-3.46
-3.72
-3.08
13.1
0
Net income
-138
-176
-757
-137
-14
-56.3
EBITDA
-136
-139
-729
-113
-74.4
-30.3
EPS, basic
-3.29
-4.18
-18.02
-3.18
-0.31
-1.23
EPS, diluted
-3.29
-4.18
-18.02
-3.18
-0.31
-1.23
Shares, basic (weighted)
42
42
42
43
45.1
45.9
Shares, diluted (weighted)
42
42
42
43
45.1
45.9
Balance sheet
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
85.6
121
160
142
131
96.8
Receivables
79.5
64.7
56
58.7
56.8
Inventory
5.1
6.66
Other current assets
26
42.2
38.9
32.5
23.6
Total current assets
277
332
317
305
267
Property, plant and equipment
57.5
47.8
41.6
44.5
51.9
Lease right-of-use assets
61.8
52.9
39.9
30.1
27.6
Goodwill
532
537
0
0
Intangible assets
271
264
207
164
129
Other non-current assets
19.2
33.2
32.8
24.1
27.3
Total assets
1,229
737
674
668
616
Accounts payable
7.36
14.9
20.8
17
12.4
Accrued liabilities
84.4
110
110
94.4
82.2
Deferred revenue
28.2
25.4
28.1
24
16.1
Short-term debt
50
0
Total current liabilities
120
150
165
185
111
Long-term debt
50
50
0
40
Lease liabilities
49
42.7
30.6
19.9
21.5
Other non-current liabilities
5.67
13
4.58
11
13.1
Total liabilities
213
288
287
239
202
Total debt
50
50
27.7
27.7
Paid-in capital
1,136
1,213
1,275
1,314
Retained earnings
-669
-805
-839
-896
Other comprehensive income
-0.68
-4.12
-2.87
-6.08
-4.44
Shareholders' equity
1,025
463
404
429
Minority interests
-9.21
-14.4
-17.1
Total equity
1,080
1,016
449
387
429
414
Total liabilities and equity
1,229
737
674
668
616
Shares outstanding
0
42.1
44.2
44.3
46.9
Cash flow statement
FY2020
FY2022
FY2022
FY2023
FY2024
FY2025
Net income
-141
-179
-761
-140
-0.87
-56.3
Depreciation and amortization
16.7
22.6
20.5
16.6
12.6
13.4
Stock-based compensation
19.2
33.5
45.3
69.5
60.5
40.7
Deferred income tax
-20.3
6.91
-9.39
-8.6
-2.93
2.26
Change in receivables
-10.8
-2.42
17.5
5.72
-5.5
-0.59
Change in payables
-3.11
-4.02
6.63
5.07
-3.04
-4.7
Cash from operations
-23.8
-23.5
-28.4
0.06
-55.3
-0.52
Capital expenditures
-6.6
-8.89
-13.1
-6.82
-5.04
-5.38
Cash from investing
26.5
-21.5
-64.8
-12.9
50.8
-21
Debt issued
0
0
41.1
Debt repaid
0
0
-1.1
Stock issued
11.9
7.86
5.97
Share buybacks
0
-20
0
Cash from financing
34.2
83.3
136
7.05
-19.4
-12.2
Exchange rate effect
1.37
-3.33
-3.03
0.13
0
0
Net change in cash
38.4
35.1
39.4
-5.69
-23.9
-33.7
Free cash flow
-30.4
-32.3
-41.5
-6.75
-60.4
-5.9
Interest paid
0.76
3
3.01
2.42
Income taxes paid
8.58
11.8
13.4
21.3
19.1
13
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.95 on November 10, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-1.7%
Operating income / revenue.
EBITDA margin
1.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-1.4%
Pre-tax income / revenue.
Net margin
-6.9%
Net income / revenue.
FCF margin
-0.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
1.0%
Cash from operations / revenue.
Return on assets (ROA)
-5.1%
Net income / average total assets.
R&D / revenue
23.6%
Research and development expense / revenue.
SG&A / revenue
38.0%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
6.6%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.2%
Capital expenditures / revenue.
D&A / revenue
3.4%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-9.2%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-3.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
3.6%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-15.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-5.4%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
1.5%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-7.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-5.8%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
1.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
3.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
1.8%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.38x
Current assets / current liabilities.
Quick ratio
1.22x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.71x
(Cash + short-term investments) / current liabilities.
Debt / assets
4.4%
Total debt / total assets.
Liabilities / assets
33.3%
Total liabilities / total assets.
Net debt
-$59.4M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
-7.89x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage
-2.86x
Operating income / interest expense.
Working capital
$169.3M
Current assets - current liabilities.
Goodwill and intangibles / assets
17.4%
(Goodwill + intangible assets) / total assets.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.73x
Revenue / average total assets.
Fixed asset turnover
7.69x
Revenue / average property, plant and equipment.
Receivables turnover
7.38x
Revenue / average receivables.
Days sales outstanding
49 days
365 x average receivables / revenue.
Capex / operating cash flow
113.4%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.65
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Market cap + total debt - cash - short-term investments.
P/S
0.63x
Market cap / revenue.
P/OCF
61.3x
Market cap / cash from operations, when positive.
EV/Sales
0.50x
Enterprise value / revenue.
EV/EBITDA
30.7x
Enterprise value / EBITDA, when both are positive.
FCF yield
-0.2%
Free cash flow / market cap.
Earnings yield
-10.9%
Net income / market cap (the inverse of P/E).
What was Xperi Inc.'s revenue in fiscal 2025?
Xperi Inc. reported revenue of $448.1M for fiscal 2025, 9.2% lower than the year before.
Was Xperi Inc. profitable in fiscal 2025?
No. It reported a net loss of $56.3M.
How much free cash flow did Xperi Inc. generate in fiscal 2025?
Cash from operations of $515.0K minus capital expenditures of $5.4M left free cash flow of -$5.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.